A neurologist grapples with aducanumab
I have been following the controversy surrounding the approval of the new Alzheimer’s drug aducanumab with great interest. Until a year and a half ago, I worked as a neurologist in an adult general neurology clinic. Many of my patients had dementia. While I thoroughly enjoyed seeing these patients and their family members, I often felt helpless when treating them. When I left clinical practice to explore a non-clinical career …
A neurologist grapples with aducanumab









![Smart design choices improve patient care outcomes [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-4-190x100.jpg)

![Doctors often struggle to separate professional advice from family love [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-1-190x100.jpg)
